Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & Administrative
Others
Ratios

Pasithea Therapeutics (KTTA) Gross Profit (2022)

Pasithea Therapeutics (KTTA) has disclosed Gross Profit for 1 consecutive years, with $242020.0 as the latest value for Q4 2022.

  • Quarterly Gross Profit changed N/A to $242020.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $373364.0 through Dec 2022, changed N/A year-over-year, with the annual reading at $373364.0 for FY2022, 16971.4% up from the prior year.
  • Gross Profit hit $242020.0 in Q4 2022 for Pasithea Therapeutics, up from $132143.0 in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $242020.0 in Q4 2022 to a low of -$1520.0 in Q2 2022.